Vertex Pharmaceuticals Analysts Recommendations and Consensus

VRTX -- USA Stock  

Quarterly Earning Report: October 23, 2019  

The current analyst and expert consensus on Vertex Pharmaceuticals is Buy with 5 hold recommendations. The current projected target price consensus is 214.08 with 13 analysts opinions. One of the most common ways Vertex Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Vertex Pharmaceuticals vendors, executives, and/or customers. Vertex Pharmaceuticals recommendation module provides expert sentiment on the projected Vertex Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 15.445. Also please take a look at Macroaxis Advice on Vertex Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Vertex Pharmaceuticals Target Price Consensus

Number of Opinions15
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Vertex Pharmaceuticals Target Price Projection

Current Price

Vertex Pharmaceuticals Market Quote

Low Price177.5Odds
High Price180.05Odds

177.72

Target Price

Analyst Consensus On Target Price

Low Estimate186.0Odds
High Estimate240.0Odds
Number of Analysts13
Standard Deviation15.445

214.077

Vertex Pharmaceuticals Analysit Ratings

Average Consensus

Search macroaxis.com